KRAS and dengue disease: Recent structural biology studies have identified multiple druggable sites across dengue viral proteins, including the NS3 protease active site [53], NS5 RNA-dependent RNA polymerase catalytic pocket [54], NS2B-NS3 protease allosteric sites [55], and envelope protein domain II [56].